Navigation Links
In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn

Lower-Than-Expected Patient Volumes Seen in Houston Physician-Owned Hospitals, According to New Reports from HealthLeaders-InterStudy

NASHVILLE, Tenn., March 23 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while Texas laws favoring physicians have traditionally enabled doctors practicing in the state to compete directly with health systems, these regulations may actually yield increasing challenges for this sector. According to the recent Houston Market Overview and San Antonio Market Overview, positives for the physician sector are tempered by economic conditions and a challenging contracting environment.

Texas has no certificate-of-need requirements for healthcare facilities and state law bars hospitals from employing physicians in most cases--two factors that have allowed doctors to build their own hospitals and facilities. There are more physician-owned hospitals in Texas than in any other state.

Meanwhile, the current economic environment finds many patients delaying care, a situation that will intensify as more consumers adopt health plans with higher copays and deductibles.

In the Houston market, home to more than a dozen acute-care facilities with physician investors, the area's physician-owned hospitals have an additional challenge: difficulty securing managed care contracts. Physician-owned University General Hospital and Foundation Surgical Hospital have contracts with one major insurer each--Aetna and UnitedHealth, respectively. Each hospital has seen lower-than-expected patient volumes.

"The Houston market has seen many hospitals open in recent years. For physician-owned facilities, today's environment, with reduced patient volumes and limited managed care contracts, makes it difficult for them to become profitable," said Mark Cherry, market analyst with HealthLeaders-InterStudy. "In areas like Houston and San Antonio we'll likely see physicians begin to work more closely with health systems, and consolidation among the overall health system segment as these players look to become more efficient."

Why Pharmaceutical Companies Need Market Overviews

Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas, allowing pharmaceutical executives to quickly gain local area expertise. Each report provides local-level insights into: health systems and hospitals, physicians, health plans, Medicare/Medicaid, pharmaceutical environment, legislation and employers.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Lisa Osgood                      Elizabeth Marshall
    HealthLeaders-InterStudy         Decision Resources, Inc.
    781-296-2606                     781-296-2563     

SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
2. Austin, Texas, Physicians Second in Nation to Perform New Procedure for Difficult-to-Treat Atrial Fibrillation Cases
3. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
4. Some drug studies more likely to have favorable conclusions
5. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
6. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
7. INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
8. Memry Corporation Plans to Appeal Unfavorable Court Result
9. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
10. Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
11. Non-parental care of infants tied to unfavorable feeding practices
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an ... is being more and more widely heralded as a breakthrough for performing hernia repairs. ... has over traditional laparoscopic surgery is that it can greatly reduce the pain that ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like to become ... invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will ... , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the ... Wimbledon Athletics Facebook page to educate the public, parents and school ... About 2,000 people under the age of 25 die from sudden cardiac arrest ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: